We are live on ! Find out more

PSTV

Plus Therapeutics

PSTV

Delisted

PSTV was delisted on the 31st of July, 2026.

5 hedge funds and large institutions have $11.1M invested in Plus Therapeutics in 2014 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New

Increased

Maintained

Reduced

Closed

25% more funds holding

Funds holding: 4 → 5 (+1)

73% less capital invested

Capital invested by funds: $41.4M → $11.1M (-$30.3M)

91% less call options, than puts

Call options by funds: $8K | Put options by funds: $85K

Holders

Holders Change

Holders Change %

+25%

% of All Funds

0.15%

Holding in Top 10

–

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

–

New

Increased

–

Reduced

–

Closed

–

Calls

$8K

Puts

$85K

Net Calls

-$77K

Net Calls Change

+$320K

Top Buyers

Rank	Fund	Capital Flow
1	GCM Goldman Capital Management New York	+$4.54M

Top Sellers

Rank	Fund	Capital Flow
1	RCM Rotella Capital Management Bellevue, Washington	-$151K
2	TC TFS Capital West Chester, Pennsylvania	-$51K
3	Tudor Investment Corp Stamford, Connecticut	-$35K
4	Prudential Financial Newark, New Jersey	-$27K
5	Dimensional Fund Advisors Austin, Texas	-$26K

#	Name	Holding	Trade Value	Shares Change	Change in Stake
1	BIT 1 BlackRock Institutional Trust San Francisco, California	$1.89M	–	–	–
2	2 Vanguard Group Malvern, Pennsylvania	$1.58M	–	–	–
3	BFA 3 BlackRock Fund Advisors San Francisco, California	$1.1M	–	–	–
4	GCM 4 Goldman Capital Management New York	$1.09M	+$4.54M	+1	New
5	MCM 5 Marathon Capital Management Hunt Valley, Maryland	$626K	–	–	–
6	6 State Street Boston, Massachusetts	$602K	–	–	–
7	7 Northern Trust Chicago, Illinois	$493K	–	–	–
8	PCM 8 Perkins Capital Management Wayzata, Minnesota	$449K	–	–	–
9	9 Renaissance Technologies New York	$321K	–	–	–
10	PCMI 10 Princeton Capital Management Inc Princeton, New Jersey	$280K	–	–	–
11	11 Geode Capital Management Boston, Massachusetts	$237K	–	–	–
12	12 Bank of New York Mellon New York	$224K	–	–	–
13	RAM 13 Redmond Asset Management Henrico, Virginia	$205K	–	–	–
14	TCIM 14 TIAA CREF Investment Management New York	$177K	–	–	–
15	BCM 15 Bridgeway Capital Management Houston, Texas	$152K	–	–	–
16	BIM 16 BlackRock Investment Management Wilmington, Delaware	$138K	–	–	–
17	CB 17 Commerce Bank Kansas City, Missouri	$93K	–	–	–
18	18 Royal Bank of Canada Toronto, Ontario, Canada	$92K	–	–	–
19	19 Adage Capital Partners Boston, Massachusetts	$84K	–	–	–
20	20 California State Teachers Retirement System (CalSTRS) West Sacramento, California	$84K	–	–	–
21	21 Group One Trading Chicago, Illinois	$82K	–	–	–
22	VKH 22 Virtu KCG Holdings New York	$78K	–	–	–
23	TA 23 Teachers Advisors New York	$68K	–	–	–
24	24 California Public Employees Retirement System Sacramento, California	$67K	–	–	–
25	25 D.E. Shaw & Co New York	$60K	–	–	–

PSTV Hedge Fund Activity: Q3 2014 in Review

5 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q3 2014, worth a combined $11.1M — down 73% from $41.4M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new PSTV positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Goldman Capital Management, opening a new position worth an estimated $4.54M. The largest seller was Rotella Capital Management, cutting an estimated $151K.

5 institutional investors held Plus Therapeutics (PSTV) as of Q3 2014, up from 4 in Q2 2014.
Funds reported $11.1M of Plus Therapeutics stock for Q3 2014, down 73% quarter-over-quarter.
1 fund opened new Plus Therapeutics positions in Q3 2014 and 0 closed out, a net change of +1 holder.
The largest Plus Therapeutics buyer in Q3 2014 was Goldman Capital Management, an estimated $4.54M added.
The largest Plus Therapeutics seller in Q3 2014 was Rotella Capital Management, an estimated $151K sold.

Based on aggregated 13F filings for Q3 2014.

Plus Therapeutics PSTV